Eszopiclone, marketed by Sepracor under the brand-name Lunesta, is a nonbenzodiazepine hypnotic agent (viz., a sedative) used as a treatment for insomnia. Eszopiclone is the active dextrorotatory stereoisomer
The company said that the objective of the study was to evaluate the efficacy and safety of naproxcinod 375 mg bid and naproxcinod 750 mg bid compared with
Interferon Alpha-2b is an immune system modulator that is active against a variety of HPV-induced lesions. Interferon Alpha-2b is thought to function by triggering an antiviral response within
Aurobindo said that the grant is its 9th product approval from Health Canada. The Topiramate Tablet 25mg, 50mg, 100mg and 200mg is the generic equivalent of Janssen-Ortho, Canada’s
Biotech Alliances is an international biotechnology alliances and partnering firm that specialises in facilitating successful strategic alliances to foster growth and advancement in the biotechnology industry. Franck Brinkhaus,
Legacy Pharmaceutical Packaging, which presently has 120 employees at its 90,000sqft plant in Earth City, intends to recruit 30 workers to staff the lines, and is funding the
GSK said that the main objectives of this project are to increase visual presence at-shelf, optimize shop-ability and create clear differentiation from competitors. Janice Jaworski, managing director of
Microfluidics said that the industry and academic research teams are able to achieve superior nanoemulsions, nanosuspensions, nanoencapsulation and protein yield while minimizing quantities of limited and expensive materials
As per the terms of the agreement, Endo is expected to retain all rights to the molecules developed, while Syngene will receive research fees, milestone payments and success
Simcere Pharma said that Endostar is approved as a Class-1 drug by the State Food and Drug Administration (SFDA) for the treatment of cancer (license no S20050074). Since
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.